跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
CASPOFUNGIN APOTEX caspofungin 50 mg powder for injection glass vial
Approved
STANDARD
CASPOFUNGIN APOTEX caspofungin 50 mg powder for injection glass vial
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9ed37cc181d1e237
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
9ed37cc181d1e237
Product Name
CASPOFUNGIN APOTEX caspofungin 50 mg powder for injection glass vial
Artg Id
281114
Artg Name
CASPOFUNGIN APOTEX caspofungin (as acetate) 50 mg powder for injection glass vial
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2017-09-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9ed37cc181d1e237
Type
Standard
Back to TGA Approvals
CASPOFUNGIN APOTEX caspofungin 50 mg powder for injection glass vial - TGA Drug Approval Details
